Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Journal of Clinical Gastroenterology|June 12, 2013
Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinomaJudith Meza-Junco, Aldo J Montano-Loza, Vickie E Baracos, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2006
Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfaVincent G Bain, Eric M Yoshida, Kelly D Kaita, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 21, 2018
Quantitative blood flow evaluation of vasodilation-stress compared with dobutamine-stress in patients with end-stage liver disease using 82Rb PET/CTJonathan T Abele, Monique Raubenheimer, Vincent G Bain, et al.European Journal of Gastroenterology & Hepatology|March 11, 2010
Identifying HCV genotype 1 patients at risk of relapseMarc Deschênes, Vincent G Bain, Samuel S Lee, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2008
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Paul Marotta, et al.Transplantation|May 15, 2007
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effectsChristian Toso, Glenda A Meeberg, David L Bigam, et al.Hepatology (Baltimore, Md.)|July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CStefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimusNazira Chatur, Alnoor Ramji, Vincent G Bain, et al.Journal of Hepatology|June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis CStefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Late acute rejection after liver transplantation: the Western Canada experienceAlnoor Ramji, Eric M Yoshida, Vincent G Bain, et al.Pageof 6